BIOMAT Database Logo BIOMAT Database Logo

Progestogen-estrogen therapy in the menopause. A double blind study. 1967

M L Taymor, and T H Rizkallah

UI MeSH Term Description Entries
D008593 Menopause The last menstrual period. Permanent cessation of menses (MENSTRUATION) is usually defined after 6 to 12 months of AMENORRHEA in a woman over 45 years of age. In the United States, menopause generally occurs in women between 48 and 55 years of age. Change of Life, Female
D009640 Norethindrone A synthetic progestational hormone with actions similar to those of PROGESTERONE but functioning as a more potent inhibitor of ovulation. It has weak estrogenic and androgenic properties. The hormone has been used in treating amenorrhea, functional uterine bleeding, endometriosis, and for CONTRACEPTION. 19-Norpregn-4-en-20-yn-3-one, 17-hydroxy-, (17alpha)-,Ethinylnortestosterone,Norethisterone,Norpregneninolone,Conceplan,Micronor,Monogest,Nor-QD,Norcolut,Norcolute,Norethindrone, (1 beta)-Isomer,Norlutin,Nor QD,NorQD
D004997 Ethinyl Estradiol A semisynthetic alkylated ESTRADIOL with a 17-alpha-ethinyl substitution. It has high estrogenic potency when administered orally, and is often used as the estrogenic component in ORAL CONTRACEPTIVES. 19-Norpregna-1,3,5(10)-trien-20-yne-3,17-diol, (17alpha)-,Ethynyl Estradiol,Estinyl,Ethinyl Estradiol Hemihydrate,Ethinyl Estradiol, (8 alpha)-Isomer,Ethinyl Estradiol, (8 alpha,17 alpha)-Isomer,Ethinyl Estradiol, (8 alpha,9 beta,13 alpha,14 beta)-Isomer,Ethinyl Estradiol, (9 beta,17 alpha)-Isomer,Ethinyl-Oestradiol Effik,Ethinylestradiol Jenapharm,Ethinyloestradiol,Lynoral,Microfollin,Microfollin Forte,Progynon C,Estradiol, Ethinyl,Estradiol, Ethynyl,Ethinyl Oestradiol Effik,Hemihydrate, Ethinyl Estradiol,Jenapharm, Ethinylestradiol
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

M L Taymor, and T H Rizkallah
Estrogen and combined estrogen-progestogen therapy in the menopause and breast cancer.
December 2004, Breast (Edinburgh, Scotland),
M L Taymor, and T H Rizkallah
Estrogen-progestogen therapy during menopause. Renewed interest in the 1980s.
November 1986, Postgraduate medicine,
M L Taymor, and T H Rizkallah
Graded sequential therapy in the menopause: a double-blind study.
September 1971, American journal of obstetrics and gynecology,
M L Taymor, and T H Rizkallah
The menopause: benefits and risks of estrogen-progestogen replacement therapy.
April 1982, Fertility and sterility,
M L Taymor, and T H Rizkallah
Combined estrogen and progestogen for the menopause.
January 1980, Acta obstetricia et gynecologica Scandinavica,
M L Taymor, and T H Rizkallah
Comparison of the effects of tibolone and estrogen therapy on hemostasis in surgical menopause: a randomized, double-blind, placebo-controlled study.
April 2007, Fertility and sterility,
M L Taymor, and T H Rizkallah
Combined estrogen-progestogen contraceptives and combined estrogen-progestogen menopausal therapy.
January 2007, IARC monographs on the evaluation of carcinogenic risks to humans,
M L Taymor, and T H Rizkallah
A double-blind study of progestogen treatment in spontaneous abortion. (Preliminary report).
December 1965, The Journal of obstetrics and gynaecology of the British Commonwealth,
M L Taymor, and T H Rizkallah
Sequential estrogen-progestogen therapy in gynecology.
January 1966, American journal of obstetrics and gynecology,
M L Taymor, and T H Rizkallah
[Continuous graduated sequential therapy with estrogen-gestagen in the climacteric. A double-blind study].
March 1976, Ugeskrift for laeger,
Copied contents to your clipboard!